Speaker To Be Announced

Speaker To Be Announced

Company: Natera


Informed By The Tumor: The Power of a Personalized ctDNA Assay For MRD Detection & Monitoring in NSCLC 3:30 pm

Latest clinical data from 2022 publications and presentations Advantages of a personalized, tumor-informed ctDNA assay for molecular residual disease detection Applications of Signatera in clinical trial design to maximize trial success, and accelerate time to data readoutRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.